Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™
ABIM Diplomates - maximum of 0.25 ABIM MOC points
Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)
Pharmacists - 0.25 Knowledge-based ACPE (0.025 CEUs)
IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit
This activity is intended for all primary care physicians, critical care specialists, infectious disease specialists, pharmacists, nurses and other healthcare professionals who treat and manage adults with known or suspected COVID-19 infection.
The goal of this activity is to distinguish the best practice in cardiopulmonary resuscitation for patients with known or suspected COVID-19 infection.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.
Medscape, LLC designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number JA0007105-0000-22-057-H01-P).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 3/11/2022
Valid for credit through: 3/11/2023
processing....
Note: The information on the coronavirus outbreak is continually evolving. The content within this activity serves as a historical reference to the information that was available at the time of this publication. We continue to add to the collection of activities on this subject as new information becomes available. It is the policy of Medscape Education to avoid the mention of brand names or specific manufacturers in accredited educational activities. However, manufacturer names related to COVID-19 vaccines may be provided in this activity to promote clarity. The use of manufacturer names should not be viewed as an endorsement by Medscape of any specific product or manufacturer.
Survival of cardiac arrest both within the hospital and in the community have declined precipitously since the advent of the pandemic, according to the authors of a recent 2022 interim guidance on CPR/ACLS in known or suspected COVID-19 patients. Several factors could explain these results, such as the severity of SARS-CoV-2 related cardiac arrest, the implementation or termination of resuscitation guidance, local crisis standards of care or patient hesitancy to seek medical care contributing to delays in care.
The provision of prompt chest compressions and defibrillation may also have been delayed due to the additional time required in donning personal protective equipment (PPE) or securing the airway and the PPE may have accelerated rescuer fatigue resulting in decreased CPR quality of which is a lack of PPE or delay in resuscitation resulting from the time required to don PPE.
Experts recommend that the resuscitation team wear PPE for all aerosol-generating procedures (AGPs) involving patients with known or suspected COVID-19. AGPs include chest compressions, defibrillation, bag-mask ventilation, intubation, and positive-pressure ventilation. The current interim guidance highlights specific recommendations for in-hospital resuscitation.
Based on new and more transmittable COVID-19 strains, declining vaccine effectiveness and feedback from the healthcare community, it became clear that that there was a need to create interim guidance for basic and advanced life support. The American Heart Association, working with the American Academy of Pediatrics, the American Association for Respiratory Care, the Society of Critical Care Anesthesiologists, and the American Society of Anesthesiologists, have issued the 2022 Interim Guidance for Basic and Advanced Life Support in Adults, Children and Neonates with Suspected or Confirmed COVID-19.
The updated guidance was published online January 24th, 2022, in Circulation: Cardiovascular Quality and Outcomes. The goal was to fully protect healthcare providers who perform resuscitation and highlights specific recommendations for in-hospital resuscitation. The guidance can be considered a best practice statement and have not gone through a formal evidence review and subsequently, cannot be assigned a Class of Recommendation or Level of Evidence. The guidance is based on available scientific evidence at the time of its development and will continue to evolve as the pandemic continues.
Updates in the interim guidance focus on three tenets:
1. Incorporating the most recent Centers for Disease Control and Prevention and World Health Organization guidance
All healthcare providers should wear a respirator (eg, N95) along with other PPE (gown, gloves, and eye protection) for patients with suspected or confirmed COVID-19 infection before performing Aerosol-generating procedures (AGPs) or in a setting where such procedures are regularly performed. This may also apply to patients in cardiac arrest who tested negative for COVID-19 on admission. In the event initial responders are not already wearing appropriate PPE, they should immediately don it and then begin CPR.
(AGPs) include chest compressions, defibrillation, bag-mask ventilation, intubation, and positive-pressure ventilation.
2. Reinforcing resuscitation best practices
Cardiac arrest survival is dependent on early initiation of CPR and performing chest compressions as soon as it is safely possible is recommended. Patients with confirmed or suspected COVID-19 should receive the best resuscitative efforts possible.
3. Ensuring adequate PPE supply
Effective use of PPE is critical for the safety of healthcare providers performing resuscitations, and at this time, all healthcare providers should be following appropriate precautions and should have access to PPE in all clinical settings, regardless of the potential of encountering resuscitation events.
"Healthcare professionals are paramount to the health of communities around the world, especially during a pandemic, and they should be protected while performing healthcare procedures, including resuscitation," Dianne Atkins, MD, pediatric cardiologist, and lead author of the new interim guidance, said in a news release.
"Protecting the health and safety of healthcare professionals remains critical and includes ensuring the recommended [PPE] is available and that healthcare professionals are trained to use it properly," added Dr Atkins, who chairs the AHA emergency cardiovascular care committee.
Circ Cardiovasc Qual Outcomes. Published online January 24, 2022.[1]